Catalent expands packaging capabilities in Singapore

Published on: 

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-07-01-2015, Volume 11, Issue 7

Catalent’s Singapore facility is awarded GMP certification.


Catalent announced on June 16 that it has expanded its Singapore facility to provide secondary packaging and labeling capabilities. The site, which recently received GMP approval from the Health Science Authority, is now approved for GMP across all its activities, including secondary packaging, label printing, storage, distribution, returns and destruction management.


Catalent offers clinical supply systems and facilities in the United States, United Kingdom, Germany, Singapore and China, and a network of more than 60 audited depots. The company reports that it can handle a range of international compliance and distribution requirements, and reduce customer turnaround time.

Source: Catalent